Citation Impact
Citing Papers
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
2019
Microbiota in health and diseases
2022 Standout
Interaction between microbiota and immunity in health and disease
2020 Standout
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
2020
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Non-alcoholic fatty liver disease
2021 Standout
The intestinal microbiota fuelling metabolic inflammation
2019
Adaptive immunity in HBV infection
2016
Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes
2017
Gut microbiota in human metabolic health and disease
2020 Standout
The gut–liver axis and the intersection with the microbiome
2018
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
2019
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
2020
Works of Xiaoling Chen being referenced
Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
2016
Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet
2013
An immunodominant HLA-A*1101-restricted CD8+ T-cell response targeting hepatitis B surface antigen in chronic hepatitis B patients
2013